Autor: |
Salamaga B; Krebs Institute, University of Sheffield, Sheffield, United Kingdom.; Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, United Kingdom., Prajsnar TK; Krebs Institute, University of Sheffield, Sheffield, United Kingdom.; Department of Infection and Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; The Bateson Centre, University of Sheffield, Sheffield, United Kingdom., Jareño-Martinez A; Krebs Institute, University of Sheffield, Sheffield, United Kingdom.; Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, United Kingdom., Willemse J; Institute of Biology, Leiden University, Leiden, The Netherlands., Bewley MA; Krebs Institute, University of Sheffield, Sheffield, United Kingdom.; Department of Infection and Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Chau F; INSERM, UMR 1137, Infection, Antimicrobiens Modelisation, Evolution (IAME), Université Paris Diderot, Sorbonne Paris cité, Paris, France., Ben Belkacem T; Krebs Institute, University of Sheffield, Sheffield, United Kingdom.; Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, United Kingdom., Meijer AH; Institute of Biology, Leiden University, Leiden, The Netherlands., Dockrell DH; Krebs Institute, University of Sheffield, Sheffield, United Kingdom.; Department of Infection and Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Renshaw SA; Krebs Institute, University of Sheffield, Sheffield, United Kingdom.; Department of Infection and Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; The Bateson Centre, University of Sheffield, Sheffield, United Kingdom., Mesnage S; Krebs Institute, University of Sheffield, Sheffield, United Kingdom.; Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, United Kingdom. |